GLP-1 Sulfur Burps: Why They Happen and How to Stop Them

Sulfur burps can appear suddenly during GLP-1 therapy and often catch people off guard.

GLP-1 Sulfur Burps: Why They Happen and How to Stop Them

Few side effects surprise people starting GLP-1 medications more than sulfur burps.

The experience is unmistakable. A sudden rotten-egg smell when belching, often appearing a few days or weeks after beginning medications such as semaglutide or tirzepatide. For many people it seems bizarre and alarming. The immediate thought is that something abnormal must be happening in the stomach.

In reality, sulfur burps are not a mysterious reaction and they do not mean food is “rotting” inside the body. They are the predictable result of two normal biological processes interacting with each other: the way GLP-1 medications slow digestion, and the way gut bacteria produce gas when they break down certain nutrients.

Understanding those two systems explains nearly everything about why sulfur burps occur and why they usually improve over time.

What Are GLP-1 Sulfur Burps?

Normal digestion moves food steadily from the stomach into the small intestine where nutrient absorption occurs.

A sulfur burp is simply a belch that contains hydrogen sulfide gas.

Hydrogen sulfide is a naturally occurring gas produced in the digestive tract. It is the same compound responsible for the smell of rotten eggs. The human gut generates small amounts of it every day as bacteria break down sulfur-containing compounds in food.

Foods rich in sulfur amino acids are common sources. Eggs, meat, dairy proteins, garlic, onions, and cruciferous vegetables like broccoli and cabbage all contain sulfur compounds that bacteria metabolize during digestion.

Normally this gas forms gradually in the intestines and moves along with the digestive process. Most of it is absorbed, neutralized, or passed through the lower digestive tract.

A sulfur burp happens when some of that hydrogen sulfide gas travels upward and is released during belching instead.

The gas itself is not unusual. What changes with GLP-1 medications is how digestion is timed, which can allow the gas to accumulate and become noticeable.

The Digestive System’s Timing Problem

GLP-1 medications slow gastric emptying. Food may remain in the stomach significantly longer than during normal digestion.

To understand sulfur burps, it helps to understand how the stomach normally moves food.

After eating, the stomach mixes food with digestive acid and enzymes. The resulting mixture gradually passes through the pyloric valve into the small intestine. This process is called gastric emptying.

Under normal conditions gastric emptying is tightly regulated. Food leaves the stomach at a controlled pace that allows the small intestine to absorb nutrients efficiently.

GLP-1 receptor agonists intentionally slow this process.

GLP-1 is a hormone naturally released by the intestine after meals. One of its main jobs is signaling the stomach to empty more slowly so that blood sugar rises gradually instead of spiking rapidly.

Medications that mimic GLP-1 amplify that signal. As a result, food remains in the stomach longer than usual.

This effect contributes to several benefits of the medication. It increases satiety, helps control blood glucose levels, and reduces appetite. But the same delay also changes the environment in which digestion occurs.

Food sitting in the stomach longer alters how gases form and move through the digestive tract.

Where the Sulfur Gas Actually Comes From

Gut bacteria break down sulfur-containing nutrients and release hydrogen sulfide gas, which produces the characteristic rotten egg smell.

The sulfur smell does not originate in the stomach itself. It comes primarily from bacterial metabolism in the intestines.

The human gut contains trillions of bacteria. Many of them help digest nutrients that human enzymes cannot fully break down. During this process they produce various gases including hydrogen, methane, carbon dioxide, and hydrogen sulfide.

Hydrogen sulfide forms when bacteria metabolize sulfur-containing molecules such as cysteine and methionine. These molecules are common in dietary proteins.

Normally the gas produced by bacteria travels downward through the intestines. It eventually dissipates or exits through the lower digestive tract.

However, when gastric emptying slows significantly, the timing of digestion shifts.

Food may spend longer in the stomach while gas produced further along in the digestive system moves upward. Gas can also accumulate when digestion is delayed and the digestive tract temporarily holds more partially digested food.

When pressure builds in the upper digestive tract, the body releases that pressure through belching. If hydrogen sulfide is present in the gas mixture, the burp carries the characteristic sulfur smell.

Why GLP-1 Medications Increase Belching

Beyond delayed gastric emptying, GLP-1 medications also influence upper gastrointestinal motility, meaning how muscles in the digestive tract move food and gas.

The stomach and esophagus rely on coordinated muscle contractions to move material in the correct direction. These movements are controlled by complex nerve signaling between the gut and the brain.

GLP-1 receptor activation affects this signaling. It slows stomach contractions and alters how quickly the stomach clears gas.

When gas is released more slowly or accumulates in the upper stomach, belching becomes more likely.

This is why belching is listed among the gastrointestinal side effects reported in clinical trials of GLP-1 receptor agonists.

Most of the time these burps contain ordinary digestive gases. When hydrogen sulfide is present, the odor becomes noticeable.

Why Some People Experience Sulfur Burps and Others Do Not

Meals high in sulfur-containing foods such as broccoli, Brussels sprouts, and protein-rich meats can increase hydrogen sulfide gas during digestion.

Not everyone taking GLP-1 medications develops sulfur burps, and several biological factors likely explain the difference.

The first is the gut microbiome. Every person carries a unique community of bacteria in their digestive tract. Some bacterial species produce more hydrogen sulfide than others when metabolizing protein and sulfur compounds.

People whose microbiome contains more sulfur-producing bacteria may simply generate more of the gas during digestion.

Diet also plays a role. High-protein meals, eggs, and certain vegetables increase sulfur substrate available for bacterial metabolism. When these foods are eaten in large amounts, hydrogen sulfide production can increase.

Dose escalation is another common trigger. Sulfur burps are frequently reported during the early stages of treatment or shortly after increasing the medication dose. At these points gastric emptying slows more dramatically while the body is still adapting.

Finally, people differ in how sensitive they are to digestive gas and belching reflexes. Some individuals rarely burp at all, while others do so easily when pressure builds in the stomach.

Will GLP-1 Sulfur Burps Last Forever?

For many people, digestive side effects improve over time as the body adapts to GLP-1 medications.

For most people they do not.

Several adaptive processes occur during long-term GLP-1 therapy.

The stomach gradually adjusts to slower gastric emptying. Research shows that although the initial delay can be pronounced, the digestive system often partially compensates over time. The stomach begins coordinating its contractions more efficiently under the new hormonal signaling.

The gut microbiome may also shift. Bacterial populations respond to changes in diet, digestion speed, and intestinal environment. Over time the composition of bacteria can change in ways that reduce gas production.

As these adaptations occur, sulfur burps often decrease or disappear.

However, occasional episodes can still occur, especially after large meals or foods that promote gas production.

What Research Supports

Clinical trials and mechanistic studies consistently demonstrate that GLP-1 receptor agonists slow gastric emptying and alter gastrointestinal motility.

These effects are well documented in studies involving medications such as semaglutide, liraglutide, and tirzepatide.

Trials also report gastrointestinal side effects including nausea, vomiting, abdominal fullness, and belching. These symptoms occur because the medications deliberately change digestive timing and gut signaling.

Separate research on gut microbiology confirms that intestinal bacteria produce hydrogen sulfide when breaking down sulfur-containing amino acids from dietary protein.

When these two well-established biological processes intersect, sulfur burps become an understandable consequence.

What Research Does NOT Support

Sulfur burps do not indicate that food is decomposing or “rotting” in the stomach. The stomach is a highly acidic environment designed to break food down rapidly.

There is also no evidence that sulfur burps represent toxicity or damage caused by GLP-1 medications.

Another misconception is that they signal medication failure or reduced weight-loss effectiveness. Current research shows no relationship between belching symptoms and the metabolic benefits of these drugs.

In most cases sulfur burps represent a benign digestive response to altered gastrointestinal motility.

Practical Ways to Reduce GLP-1 Sulfur Burps

Several simple strategies can help reduce sulfur burps while the body adapts to GLP-1 therapy.

Smaller meals are often the most effective adjustment. Large meals remain in the stomach longer and increase the amount of digestive gas that can accumulate.

Eating more slowly also reduces swallowed air and decreases pressure in the stomach.

Some individuals benefit from temporarily limiting foods high in sulfur compounds, especially eggs and very high-protein meals, during the early stages of treatment.

Remaining upright after eating allows gas to move through the digestive tract more easily rather than accumulating in the stomach.

Light activity and staying upright after meals may help digestive gas move through the gastrointestinal tract more easily.

Gradual dose escalation when starting GLP-1 therapy is another useful approach. Allowing the digestive system time to adapt can significantly reduce gastrointestinal side effects.

When Symptoms Should Be Evaluated

Sulfur burps by themselves are usually harmless.

However, persistent symptoms accompanied by severe abdominal pain, ongoing vomiting, or inability to tolerate food should be evaluated by a healthcare professional.

These symptoms are uncommon but may indicate gastrointestinal conditions unrelated to typical medication side effects.

Conclusion

Sulfur burps often appear early during GLP-1 therapy and improve as the digestive system adapts.

Sulfur burps associated with GLP-1 medications can be unpleasant, but they are generally a predictable consequence of how these drugs influence digestion.

GLP-1 receptor activation slows gastric emptying and alters gastrointestinal motility. At the same time, gut bacteria continue producing gases as they metabolize sulfur-containing nutrients. When digestive timing changes, those gases can accumulate and be released during belching.

For most people the digestive system adapts over time and the symptom improves.

Understanding the biology behind sulfur burps removes much of the anxiety surrounding them. They are not dangerous, they do not indicate that food is rotting in the stomach, and they are not a sign that the medication is failing to work.

They are simply one of the ways the body adjusts to a medication that intentionally changes how digestion is regulated.

References

1. Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism. 2018.

2. Nauck MA, Kemmeries G, Holst JJ, Meier JJ. Rapid tachyphylaxis of the glucagon-like peptide-1 induced deceleration of gastric emptying in humans. Diabetes. 2011.

3. Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology. 2012.

4. Marathe CS, Rayner CK, Jones KL, Horowitz M. Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function. Experimental Diabetes Research. 2011.

5. Holst JJ. The physiology of glucagon-like peptide-1. Physiological Reviews. 2007.

6. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.

7. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.

8. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. FDA Drug Label.

9. U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information. FDA Drug Label.

10. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Frontiers in Physiology. 2012.

11. Wallace JL, Wang R. Hydrogen sulfide-based therapeutics: Exploiting a unique but ubiquitous gasotransmitter. Nature Reviews Drug Discovery. 2015.

12. Pitcher MC, Cummings JH. Hydrogen sulphide: A bacterial toxin in ulcerative colitis? Gut. 1996.

Disclaimer

The information presented in this article is provided for educational and informational purposes only. It is not intended to serve as medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications that should only be used under the supervision of a licensed healthcare professional.

Digestive responses to medications can vary significantly between individuals. Symptoms such as sulfur burps, nausea, or other gastrointestinal effects may occur in some users and not others. Anyone experiencing persistent or concerning symptoms should consult a qualified healthcare provider for evaluation and guidance.

Nothing in this article should be interpreted as a recommendation for the use of any medication, compound, or therapy. Individuals should always seek personalized medical advice from a licensed healthcare professional before starting, stopping, or adjusting any medical treatment.